A newly proposed rule that would require drug manufacturers to report discontinuance or interruptions in manufacturing of certain products to the U.S. Food and Drug Administration would apply to all approved drugs and biologics, including controlled substances. Drugs covered by the proposed rule include any approved controlled substances, including morphine and fentanyl, both of w... Read More